Isavuconazonium Sulfate

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 8 records

Isavuconazonium Sulfate 3 markets · 8 records Forms
Filters
MarketAU 4SG 2FR 2

AU 4 records · 3 shown of 3 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 186.3 mgcapsuleCRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister packISAVUCONAZOLE ADVZ isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack also in FR unknown
  • 74.5 mgcapsuleCRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack unknown
  • 372.6 mg per mL / per unit basis not statedinjectionCRESEMBA isavuconazole (as isavuconazonium sulfate) 200 mg powder for injection vial unknown

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

  • 186.3 mgcapsuleCRESEMBA 100 mg, gélule also in AU
  • 327.6 mg per mL / per unit basis not statedinjectionCRESEMBA 200 mg, poudre pour solution à diluer pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.